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The aim of this study was to investigate the effects of daytime and blood glucose levels on the propagation of cortical spreading depression (SD). Thirty-nine male Wistar rats were used. Animals were housed 5 per cage with a 12-h, light-dark cycle (lights on at 0600 h). Food and water were available ad libitum, and animals were fasted the night before the experiments. Cortical SD was recorded continuously for 3 h using Ag-AgCl agar-Ringer electrodes placed on the parietal cortex. Every 20 min, SD was elicited by 2% KCl stimulation of the frontal cortex for 1 min. After 1 h of SD-recording, blood glucose levels were measured, and animals were injected intravenously either with glucose (40% solution, 1 mL), insulin (0.3 U/100 g of body weight), or mannitol (20% solution, 1 mL). In the middle of the light period, which corresponds to zeitgeber time (ZT)5, 8 animals received glucose, 7 received insulin, and 6 received mannitol. In another experimental set, glucose or insulin was administered at ZT12 (at the end of the light period); 12 rats received glucose, and 6 received insulin. All the animals that received glucose were hyperglycaemic (P < 0.01), and the hyperglycaemia was less pronounced in the ZT12 group (P < 0.05; Student's t-test). Insulin induced acute hypoglycaemia in animals of both groups (ZT5, P < 0.02; ZT12, P < 0.05; Student's t-test). Glucose injection at ZT5 reduced SD, whereas the insulin ZT5 group showed increased SD propagation (ANOVA, P < 0.05 and 0.01, respectively). Neither glucose nor insulin injection changed SD velocity at ZT12. We concluded that blood glucose levels change the velocity of SD propagation and that these effects are influenced by the daytime. Dark periods seemed to produce a resistance to cortical SD propagation.
Crown Copyright © 2011 Published by Elsevier Ireland Ltd. All rights reserved.
During the 24-h light/dark (LD) cycle, brain electrical activity changes according to the different stages of the sleep/wake cycle. In the wake phase, electroencephalograms (EEGs) show brain waves, whose frequency can vary between 15 and 60 Hz; however, during the sleep phase, the EEG brain wave pattern slows to 0.5-8 Hz, except during the rapid eye movement (REM) sleep phase when the frequency becomes similar to the wake phase [9] . Likewise, brain metabolic activity changes with the daytime, as demonstrated in rodents by higher glucose uptake during the light phase of the LD cycle. This higher glucose uptake seems to be paralleled by a metabolic consumption of glucose through oxidative phosphorylation observed at midday, followed by a reduction at the onset of night in the LD cycle [17, 23] . Alternating light and dark phases are an important environmental cue for the areas of the suprachias-matic nuclei (SCN) that receive photoperiod information directly from the retinohypothalamic tract (RHT) and that are involved in sleep/wake and rest/activity cycles, feed regulation, nutrient absorption, and hormone secretion [11, 13] . The SCN are bilaterally located in the hypothalamus and have been described as the central pacemaker for biological rhythms. These rhythms are entrained by environmental factors, such as the 24-h LD cycle where light is the 'time-giver' that typically defines zeitgeber time (ZT)0 as the beginning of lights-on in a 12:12 LD cycle. In the absence of external cues, e.g., constant darkness, biological rhythms follow an endogenous pacemaker. In rats, the SCN generate a 24-h rhythm for the plasma concentration of glucose, which increases some hours before the onset of activity, e.g., at the beginning of the dark phase of the LD cycle [2, 4, 5] . In addition to the changes in the circadian rhythm of glucose uptake, the SCN show a circadian oscillation in the accumulation of extracellular ATP. This was observed in rat primary cultures where ATP levels in the SCN remain low; however, in the first half of the dark phase, ATP levels increase quickly [20] . Astrocytes have neuroprotective actions such as glutamate uptake and free radical scavenging, which require ATP as an energy source.
However, decreases in glucose availability, such as in deep hypoglycaemia, cause the brain to use such metabolic fuels as ketone bodies and amino acids instead of glucose. These metabolite changes can result in decreases in neurotransmitters such as glutamate and ␥-aminobutyric acid (GABA) [7, 21] . Thus, ATP, which acts as an extracellular signalling molecule in the brain, is released by astrocytes and mediates increased resistance to ischaemic damage [14] . Therefore, when extracellular ATP is decreased in neurons and astrocytes, as observed in hypoglycaemic conditions, neuronal vulnerability to stress increases, as seen by propagation of electrical brain changes during spreading depression (SD) [8, 14, 15] . Many studies have defined SD as an EEG depression characterized by a decrease in spontaneous electrical activity of the brain and accompanied by a slow potential change (SPC) in DC negative potentials, which propagate at a rate of 2-5 mm/min [6, 18, 19] .
SD propagation generates an increase in cerebral blood flow, glucose utilization, and oxygen consumption; an influx of sodium, chloride, and calcium; an efflux of potassium; and cell swelling. However, under normal metabolic conditions, the brain compensates for additional energetic needs due to changes in ionic gradients that occur during SD propagation [8, 14] . Because acute and chronic hypo-and hyperglycaemia change the velocity of SD propagation [22] , we hypothesized that administering glucose or insulin during two phases of the LD cycle, where brain metabolism is known to be higher at ZT5 and lower at ZT12, could induce differential changes in brain electrical activity similar to those during SD propagation at different times of the day. Additionally, possible effects of glycaemia on SD in different times of the LD cycle can indicate a particular effect of environmental cues on brain electrical activity.
Thirty-nine male Wistar rats (90-150 days old) from the colony at the Universidade Federal de Alagoas were used. The animals were housed 4-5 per cage in a temperature-controlled room with a 12 h:12 h LD cycle (lights on at 0600 h, lights off at 1800 h). All animal procedures were performed in accordance with the European Communities Council Directives (86/609/EEC) regarding the care and use of animals and were approved (no. 005777/2005-24) by the local Ethics Committee for Animal Research. Rats received a commercial laboratory rat chow (Purina ® do Brasil Ltda.) and water ad libitum. Animals were divided into four experimental groups: ZT5 glucose (n = 8) and ZT5 insulin (n = 7), in which blood glucose levels were changed by intravenous administration of glucose or insulin in the middle of the day; ZT12 glucose (n = 12) and ZT12 insulin (n = 6), in which animals received glucose or insulin injections at the end of the light period. After 12 h of fasting, animals were weighed and anesthetized by intraperitoneal administration of a solution of urethane + chloralose (1000 mg/kg + 40 mg/kg). For the ZT12 groups, animals were anesthetized in a room adapted with a small source of red light to maintain a maximum penumbra of 3 lux. Furthermore, a black adhesive strip was placed on the eyes of the animals from the ZT12 group to ensure that no photic stimulation could change electrical or metabolic brain activity.
After tracheotomy, a femoral cannula was used to administer the same absolute dose of either 40% glucose (1 mL) or insulin (0.3 U/100 g of body weight diluted in 0.9 mL Ringer solution). Six additional animals received an intravenous solution of mannitol (20% solution, 1 mL for each animal) to mimic possible effects of the high-osmolarity glucose solution on SD propagation. For recording SD, 3 holes of 2 mm each were drilled on the right side of the skull: 1 was placed midline in the frontal bone and used to apply 2% KCl stimulation; 2 recording electrodes were placed in the parietal bone at coordinates bregma 0 mm and −6.5 mm, 4 mm from the midline. Cortical stimulation was performed through 1-min applications of a cotton pledget soaked in 2% KCl solution every 20 min, and 2 parietal electrodes recorded the SPC that accompanied SD propagation. The SPC was continuously recorded for 3 h through Ag-AgCl (n = 6) (n = 6)
Data are means ± S.D. a Significantly different from before (***P < 0.001; **P < 0.02; *P < 0.05). b Significantly different from ZT5 GLUC after injection.
electrodes placed in plastic, pipette tips filled with 1% agar + Ringer solution on the parietal cortical surface. The reference electrode (on the nasal bones) and the 2 recording electrodes were connected to a paper apparatus recorder (Ugo Basile, Italy). Body temperature was maintained at 37 • C ± 1 • C using a heater lamp. After 1 h of SD 'base line' recording, the glycaemia of the animals was measured using a colorimetric method (glucometer; Prestige IQ ® ) and a drop of blood from the tail. Following an intravenous bolus injection of glucose, insulin, or mannitol, SD was continuously recorded for 2 h. Blood glucose levels were again measured 1 h after the injections. The velocity of SD propagation was calculated on the basis of the distance between the recording electrodes and the time required for the wave to cross this distance. Data were expressed as means (S.D.). SD velocities were averaged from each group and compared using one-way ANOVA followed by Tukey's post hoc test. Two-way ANOVA was used to evaluate ZT and glycaemia interactions on SD velocity. Body weight and glycaemia were averaged and analyzed using the Student's t-test. Basal blood glucose levels from whole animals from the ZT5 (n = 12, 67.58 [14. 97] mg/dL) and ZT12 (n = 18, 60.55 [19. 83] mg/dL) groups that were measured before glucose or insulin injection were averaged and did not show a significant difference at the 2 time points studied (P = 0.3057). Glucose injections induced a significant increase in glycaemia at ZT5 and ZT12 (Table 1) . This increase in blood glucose levels was higher in the middle (ZT5) than at the end of the light phase (ZT12). The insulin injections resulted in a significant, severe decrease in blood glucose levels, but no difference was observed according to the daytime (Table 1) .
Injection of 20% mannitol solution did not change the blood glucose levels significantly (n = 6, 66.17 [15. 99] mg/dL before and 85.33 [28.21] mg/dL after mannitol injection). Animals in the glucose group did not exhibit differences in body weight (n = 8, 337.69 [37.51] g for the ZT5 group; n = 12, 359.74 [32.41] g for the ZT12 group). In the insulin group, a significant difference in body weight was observed between the ZT5 (n = 7, 319.98 [34.86] g) and ZT12 (n = 6, 378.30 [33.09] g, Student's t-test) groups. In the mannitol group, the average weight was 318.93 (21.69) g (n = 6). Regarding the effects of 40% glucose injection on the velocity of SD propagation at ZT5, there were no changes compared to the initial velocity (Fig. 1) . However, when we compared velocities after glucose administration at ZT5, we observed a significant difference between velocities at the first and second hours after glucose injection, as well as between those at the second hour at ZT5 and after glucose injection at ZT12 (P < 0.05). Changes in blood osmolarity seemed to have no effect on the velocity of SD propagation, because there were no significant changes after mannitol injection (n = 6, 3.23 [0.87] mm/min initial velocity and 3.22 [0.82] mm/min 1 h after mannitol injection). Although glucose injection slightly decreased SD propagation, at ZT5, insulin-induced, hypoglycaemic animals showed a significant increase in the velocity of SD propagation in Fig. 1 . Variations in the cortical spreading depression (SD) velocity according to the daytime. Hyperglycaemia resulted in a reduction of SD velocity compared to the second hour after glucose injection at ZT5 and the second hour after glucose injection at ZT12. Reduction in blood glucose levels by insulin injection increased SD velocity at ZT5, and 1 h after insulin injection, values were different from those in the ZT12 group. Neither glucose nor insulin affected the SD velocity at ZT12. Each bar represents the mean (S.D.). The number of animals in each group was as follows: ZT5 glucose, n = 8; ZT12 glucose, n = 12; ZT5 insulin, n = 7 and ZT12 insulin, n = 6. ***P < 0.001, **P < 0.02, and *P < 0.05 (one-way ANOVA followed by Tukey's test).
the first (P < 0.001) and second (P < 0.05) hours of recording compared to the initial velocity before insulin injection. After insulin injection, SD velocity of propagation was higher at the first hour for the ZT5 group compared to the first and second hours for the ZT12 group (P < 0.02 and P < 0.05, respectively). When glucose or insulin was injected at the end of the light cycle (ZT12) no changes in SD propagation were observed (Fig. 1) . Comparing velocities of SD propagation for the 2 ZT groups versus the different levels of glycaemia, no significant effect of ZT was observed (F = 1.33; P = 0.255), but a significant interaction was found between ZT and glycaemia for the velocity of SD propagation (F = 6.88; P = 0.012), showing how SD manifests itself during the LD cycle.
At ZT5, the SPC of SD (Fig. 2) exhibited a significant reduction 20 min after glucose injection (P < 0.05). This reduction was followed by a longer duration of the DC negative component of the SPC (P < 0.02). In hypoglycaemic rats, SPC duration was significantly decreased (P < 0.05 for 20 and 40 min and P < 0.02 for 60 min after insulin injection) in the ZT5 group. Injections of glucose or insulin did not significantly change the duration of SPC in the ZT12 group.
The ability of peripherally administered insulin or glucose to induce differential changes in blood glucose levels according to daytime was demonstrated in our study by a more pronounced hyperglycaemia at ZT5 compared to that at ZT12, whereas severe hypoglycaemia was similar at both ZTs studied (Table 1 ). In the ZT5 insulin group, all of the animals exhibited blood glucose levels at the lower limit of detection as measured by a glucometer that had a range between 25 and 600 mg/dL. Therefore, we hypothesize that in these animals, the light phase has a potential effect on hypoglycaemic conditions. The effects of glucose fluctuation during daytime were studied by La Fleur et al. [5] , who observed that intravenous 7% glucose injections in rats resulted in slightly less hyperglycaemia at ZT14 compared to those at ZT2, ZT8, and ZT11, corresponding to the light phase of LD cycle. Although there are some methodological differences between our experiments and those of La Fleur et al. [5] , we hypothesize that at ZT12 (night onset), there was a similar effect on blood glucose levels as compared to ZT14, which corresponds to the 2 initial hours of the dark phase. These effects on blood glucose levels are evidence that the LD cycle entrains plasma glucose concentrations as was demonstrated in SCN-lesioned animals, where glucose fluctuations were abolished during the LD cycle [4] . In our experiments, basal glucose levels showed no difference between midday and the onset of night. This effect could be attributed to the fasting conditions in our animals, since La Fleur et al. [4] demonstrated that in fasting animals, glucose fluctuations were dampened during the LD cycle. During this study of a 24-h plasma profile of glucose, no significant difference was found between ZT4 and ZT12. We hypothesize that in our experiments, a similar effect of fasting on basal blood glucose levels was obtained. Fig. 2 . Slow potential change (SPC) duration of cortical spreading depression before and after changes in blood glucose levels (left panel) at ZT5 and ZT12. Hyperglycaemia initially reduced the duration of the DC potential, which was followed by a significant increase in this potential. The opposite effect was observed in hypoglycaemic animals, where a significant reduction in the SPC was demonstrated. In the right panel, a schematic picture of the SPC recording is depicted: 2% KCl cortical stimulation (S) was performed every 20 min; reference electrode (®) was placed in the nasal bones, and recording electrodes were placed in the parietal cortex (electrodes 1 and 2). Each bar represents the mean (S.D.). The number of animals in each group was as follows: ZT5 glucose, n = 8; ZT12 glucose, n = 12; ZT5 insulin, n = 7 and ZT12 insulin, n = 6. **P < 0.02 and *P < 0.05 (one-way ANOVA followed by Tukey's test).
Cortical SD propagation requires an increase of glucose uptake to supply the increased metabolic demands of astrocytes and neurons. Shapiro [16] proposes that SD propagation requires efflux of K + to the interneuronal space and a reduction of cellular volume. Astrocytes contribute to the maintenance of ionic gradients, particularly extracellular K + levels. Lian and Stringer [8] had observed that decreased metabolism in astrocytes resulted in reduction of intracellular ATP levels and increase in the susceptibility for SD deflagration. We presume that the acute hypoglycaemia in our experimental groups induced an increased susceptibility to the propagation of SD at ZT5 and that hyperglycaemia induced the opposite effect, with these results being influenced by the phase of the LD cycle.
At ZT5, insulin injection resulted in a faster propagation of cortical SD compared to the ZT12 group. According to Lian and Stringer [8] , reduction of cellular metabolism leaves the neurons unprotected and vulnerable to SD propagation. Therefore, reduction in cellular metabolism would be a favourable condition for the occurrence of SD, as demonstrated in our experiments by an increased velocity of SD propagation at ZT5 during severe hypoglycaemia. Changes in brain energy metabolism that occur in oxygen and/or glucose deprivation or even chemical anoxia, result in an accumulation of adenosine in the interstitial space as well as adenosine-mediated blockage of synaptic transmission. Adenosine can be released by pre-and post-synaptic neurons as well as the glial cells next to them and shows a circadian rhythm, which peaks at 1600 h (4 pm), 3 h before the corticosterone rhythm, and diminishes slowly during the night, maintaining low levels in the SCN during the light phase of the LD cycles [10] .
Metabolic stress in glial cells triggers SD waves and then causes loss of neuronal function; however, these actions may be delayed by the activation of A1 adenosine receptors, which preserves the electrical viability of neurons [1] . Acute changes in blood glucose levels, as during hypoglycaemia, change the velocity of SD propagation, as demonstrated previously by Ximenes-da-Silva and Guedes [22] . Our study revealed increased SD propagation at ZT5 followed by a significant decrease at ZT12. As decreased brain metabolism changes the availability of energetic fuels to the brain [8, 10] and electrical brain activity is depressed during severe hypoglycaemia [12] , we hypothesize that the light phase has a modulator effect on insulin-induced, depressed brain electrical activity, because we demonstrated that there is a significant interaction between ZT and SD velocity of propagation.
Velocity of SD propagation was not significantly affected by blood glucose levels at ZT12 on the basis of the following: (1) in insulin-injected rats, we hypothesize that the peak of extracellular ATP happens in scotophase and that ATP is quickly degraded to adenosine, which then accumulates in the extracellular space, activates purinergic receptor P2, and then increases ischaemia and SD tolerance. (2) In glucose-injected rats, we hypothesize that astrocyte metabolism increased, and accordingly, intracellular ATP increased as well. Therefore, astrocytes could play their role of increasing neuronal tolerance to propagation of SD [1, 14] . Similar to SD velocity, no changes were found in the duration of the DC negative component at ZT12. Thus, at the end of the light phase of the LD cycle, reduced brain ability to react to acute changes in glycaemia was observed as in malnourished rats, in which blood glucose levels were acutely changed by glucose or insulin administration [22] . However, at ZT5, changes in SD duration were opposed by the main effect of increase in SPC duration in hyperglycaemic animals and a sustained reduction in SPC in the hypoglycaemic ones. Previous studies [22] have demonstrated that hyperglycaemia decreased the duration and velocity of SD, whereas hypoglycaemia increased both parameters. In these experiments, the duration of changes in blood glucose levels were different from the present study, and we hypothesize that differential effects are attributable to experimental design. Regarding our results, the effects of hypoglycaemia in slowing and shortening SD at ZT12 may be related to KATP channels, which are involved in neuronal metabolism and membrane potential [3] . During insulin-induced hypoglycaemia, it was demonstrated in cultured cells from the ventromedial hypothalamus (VMH) that closing the KATP channels increased GABA levels, which hyperpolarized the VMH neurons. In our experimental model of hypoglycaemia, changes in KATP channel opening could also induce increased extracellular levels of GABA, reducing the velocity and duration of SD.
Consequently, our study has demonstrated that daytime has a significant effect on changing the pattern of brain electrical activity, with a slightly higher SD in the middle of the day (ZT5) compared to that in the early night. Variations in blood glucose levels at the 2 ZTs studied here showed that in the early night, brain electrical activity during SD had not changed in response to the availability of glucose, indicating that the brain shows some resistance or tolerance to SD propagation at this time.
